These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2274701

  • 1. Hemodynamic effects of long-term converting-enzyme inhibition in renal hypertensive rats.
    Salom MG, Salazar FJ, Fenoy FJ, Pinilla JM, Marín N, Quesada T.
    Rev Esp Fisiol; 1990 Jun; 46(2):171-6. PubMed ID: 2274701
    [Abstract] [Full Text] [Related]

  • 2. [Hemodynamic changes in the acute phase of experimental hypertension].
    Carbonell LF, Salazar J, García-Estañ J, Jiménez JL, Quesada T.
    Rev Esp Fisiol; 1983 Jun; 39(2):155-60. PubMed ID: 6622806
    [Abstract] [Full Text] [Related]

  • 3. Long-term cardiac effects of hypotensive agents in normotensive mature rats: comparison of beta-blocking agent and converting enzyme inhibition.
    Azizi M, Levy B, Salzmann JL, Cerol ML, Poitevin P, Ménard J, Michel JB.
    J Cardiovasc Pharmacol; 1989 May; 13(5):691-701. PubMed ID: 2472516
    [Abstract] [Full Text] [Related]

  • 4. [Cardiovascular effects of peptide inhibitors of the renin-substrate reaction in rats with renovascular hypertension. Goldblatt: 2 kidneys--1 clip].
    Labbé T, Bonoron-Adèle S, Geoffre S, Précigoux G, Laval M, Hospital M, Besse P.
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():183-7. PubMed ID: 3142405
    [Abstract] [Full Text] [Related]

  • 5. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
    Lappe RW, Todt JA, Wendt RL.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
    [Abstract] [Full Text] [Related]

  • 6. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I, Gonzalez W, el Amrani AI, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [Abstract] [Full Text] [Related]

  • 7. Effects of converting-enzyme inhibitor on hemodynamic actions of ANP in renal hypertensive rats.
    Salom MG, Fenoy FJ, Inglés AC, Martínez L, Quesada T.
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R365-9. PubMed ID: 2527475
    [Abstract] [Full Text] [Related]

  • 8. Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats.
    Kaufman LJ, Vollmer RR.
    J Pharmacol Exp Ther; 1985 Oct; 235(1):128-34. PubMed ID: 3900340
    [Abstract] [Full Text] [Related]

  • 9. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
    Levenson J, Simon A, Temmar M, Safar M.
    Nouv Presse Med; 1980 Feb 23; 9(9):617-9. PubMed ID: 6987622
    [Abstract] [Full Text] [Related]

  • 10. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug 23; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 11. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K, Minato H, Nakatsuji K, Suzuki H, Nose I, Oka M, Hosoki K, Hatano N, Kadokawa T.
    Arzneimittelforschung; 1986 Aug 23; 36(1):69-73. PubMed ID: 3513779
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.
    J Pharmacol Exp Ther; 1995 Nov 23; 275(2):745-52. PubMed ID: 7473162
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic converting enzyme inhibition on the structure and function of large arteries in the rat.
    Levy BI, Michel JB, Salzmann JL, Devissaguet M, Camilleri JP, Safar ME.
    Clin Exp Hypertens A; 1989 Nov 23; 11 Suppl 2():487-98. PubMed ID: 2605798
    [Abstract] [Full Text] [Related]

  • 14. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK, Herzer WA, Mi Z, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct 23; 291(1):115-23. PubMed ID: 10490894
    [Abstract] [Full Text] [Related]

  • 15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan 23; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
    Giudicelli JF, Richer C, Richard C, Thuillez C.
    Am J Hypertens; 1991 Mar 23; 4(3 Pt 2):258S-262S. PubMed ID: 2043315
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
    Januszewicz A, Lapiński M, Styś T, Styś A, Loń S.
    Pol J Pharmacol; 1994 Mar 23; 46(3):153-61. PubMed ID: 8000447
    [Abstract] [Full Text] [Related]

  • 18. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ, Simpson K, Guntupalli J.
    Magnesium; 1987 Mar 23; 6(3):136-49. PubMed ID: 3626625
    [Abstract] [Full Text] [Related]

  • 19. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
    Manson NH, Hess ML.
    Circ Shock; 1984 Mar 23; 12(3):177-89. PubMed ID: 6325034
    [Abstract] [Full Text] [Related]

  • 20. Different hemodynamic response after acute diuresis in the normotensive and hypertensive state.
    Charocopos F, Hatzinikolaou P, Dipetti D.
    J Pharmacol Exp Ther; 1982 May 23; 221(2):315-8. PubMed ID: 7042955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.